Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies
Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by the destruction of joint tissues including cartilage and bone. Cartilage degradation is attributed to metalloproteinases (MPs) that belong to matrix metalloproteinase family and a disintegrin and metalloprotease with throm...
Main Author: | Itoh, Y |
---|---|
Other Authors: | Khalil, R |
Format: | Book section |
Published: |
Elsevier
2017
|
Similar Items
-
Immunomodulatory roles of metalloproteinases in rheumatoid arthritis
by: Yanqin Bian, et al.
Published: (2023-11-01) -
Role of matrix metalloproteinases in joint destruction in rheumatoid arthritis
by: R. Y. Kashevarov
Published: (2004-08-01) -
Rheumatoid arthritis: current therapeutics compendium
by: Dariushnejad Hassan, et al.
Published: (2022-04-01) -
T-Follicular Regulatory Cells: Potential Therapeutic Targets in Rheumatoid Arthritis
by: Tingting Ding, et al.
Published: (2019-11-01) -
Molecular therapeutic targets in rheumatoid arthritis.
by: Sacre, S, et al.
Published: (2005)